Your browser doesn't support javascript.
loading
Asparagine Synthetase Marks a Distinct Dependency Threshold for Cardiomyocyte Dedifferentiation.
Zhu, Yike; Ackers-Johnson, Matthew; Shanmugam, Muthu K; Pakkiri, Leroy Sivappiragasam; Drum, Chester Lee; Chen, Yanpu; Kim, Johnny; Paltzer, Wyatt G; Mahmoud, Ahmed I; Tan, Wilson Lek Wen; Lee, Mick Chang Jie; Jiang, Jianming; Luu, Danh Anh Tuan; Ng, Shi Ling; Li, Peter Yi Qing; Wang, Anhui; Qi, Rong; Ong, Gabriel Jing Xiang; Ng, Timothy Yu; Haigh, Jody J; Tiang, Zenia; Richards, A Mark; Foo, Roger S Y.
Afiliação
  • Zhu Y; Cardiovascular Research Institute, Yong Loo Lin School of Medicine, National University of Singapore (Y.Z., M.A.-J., M.K.S., L.S.P., C.L.D., W.L.W.T., M.C.J.L., J.J., L.D.A.T., S.L.N., P.Y.Q.L. G.J.X.O., T.Y.N., Z.T., A.M.R., R.S.Y.F.).
  • Ackers-Johnson M; Cardiovascular Metabolic Disease Translational Research Programme (Y.Z., M.A.-J., M.K.S., L.S.P., C.L.D., W.L.W.T., M.C.J.L., J.J., L.D.A.T., S.L.N., P.Y.Q.L. G.J.X.O., T.Y.N., Z.T., A.M.R., R.S.Y.F.), National University Health Systems, Singapore.
  • Shanmugam MK; Cardiovascular Research Institute, Yong Loo Lin School of Medicine, National University of Singapore (Y.Z., M.A.-J., M.K.S., L.S.P., C.L.D., W.L.W.T., M.C.J.L., J.J., L.D.A.T., S.L.N., P.Y.Q.L. G.J.X.O., T.Y.N., Z.T., A.M.R., R.S.Y.F.).
  • Pakkiri LS; Cardiovascular Metabolic Disease Translational Research Programme (Y.Z., M.A.-J., M.K.S., L.S.P., C.L.D., W.L.W.T., M.C.J.L., J.J., L.D.A.T., S.L.N., P.Y.Q.L. G.J.X.O., T.Y.N., Z.T., A.M.R., R.S.Y.F.), National University Health Systems, Singapore.
  • Drum CL; Cardiovascular Research Institute, Yong Loo Lin School of Medicine, National University of Singapore (Y.Z., M.A.-J., M.K.S., L.S.P., C.L.D., W.L.W.T., M.C.J.L., J.J., L.D.A.T., S.L.N., P.Y.Q.L. G.J.X.O., T.Y.N., Z.T., A.M.R., R.S.Y.F.).
  • Chen Y; Cardiovascular Metabolic Disease Translational Research Programme (Y.Z., M.A.-J., M.K.S., L.S.P., C.L.D., W.L.W.T., M.C.J.L., J.J., L.D.A.T., S.L.N., P.Y.Q.L. G.J.X.O., T.Y.N., Z.T., A.M.R., R.S.Y.F.), National University Health Systems, Singapore.
  • Kim J; Cardiovascular Research Institute, Yong Loo Lin School of Medicine, National University of Singapore (Y.Z., M.A.-J., M.K.S., L.S.P., C.L.D., W.L.W.T., M.C.J.L., J.J., L.D.A.T., S.L.N., P.Y.Q.L. G.J.X.O., T.Y.N., Z.T., A.M.R., R.S.Y.F.).
  • Paltzer WG; Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany (C.Y., J.K.).
  • Mahmoud AI; Cardiovascular Research Institute, Yong Loo Lin School of Medicine, National University of Singapore (Y.Z., M.A.-J., M.K.S., L.S.P., C.L.D., W.L.W.T., M.C.J.L., J.J., L.D.A.T., S.L.N., P.Y.Q.L. G.J.X.O., T.Y.N., Z.T., A.M.R., R.S.Y.F.).
  • Tan WLW; Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany (C.Y., J.K.).
  • Jiang J; Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany (C.Y., J.K.).
  • Luu DAT; German Centre for Cardiovascular Research (DZHK), Partner site Rhein/Main, Bad Nauheim (J.K.).
  • Ng SL; Department of Cell and Regenerative Biology, School of Medicine and Public Health, University of Wisconsin-Madison (W.G.P., A.I.M.).
  • Li PYQ; Department of Cell and Regenerative Biology, School of Medicine and Public Health, University of Wisconsin-Madison (W.G.P., A.I.M.).
  • Wang A; Cardiovascular Research Institute, Yong Loo Lin School of Medicine, National University of Singapore (Y.Z., M.A.-J., M.K.S., L.S.P., C.L.D., W.L.W.T., M.C.J.L., J.J., L.D.A.T., S.L.N., P.Y.Q.L. G.J.X.O., T.Y.N., Z.T., A.M.R., R.S.Y.F.).
  • Qi R; Cardiovascular Metabolic Disease Translational Research Programme (Y.Z., M.A.-J., M.K.S., L.S.P., C.L.D., W.L.W.T., M.C.J.L., J.J., L.D.A.T., S.L.N., P.Y.Q.L. G.J.X.O., T.Y.N., Z.T., A.M.R., R.S.Y.F.), National University Health Systems, Singapore.
  • Ong GJX; Cardiovascular Research Institute, Yong Loo Lin School of Medicine, National University of Singapore (Y.Z., M.A.-J., M.K.S., L.S.P., C.L.D., W.L.W.T., M.C.J.L., J.J., L.D.A.T., S.L.N., P.Y.Q.L. G.J.X.O., T.Y.N., Z.T., A.M.R., R.S.Y.F.).
  • Ng TY; Cardiovascular Metabolic Disease Translational Research Programme (Y.Z., M.A.-J., M.K.S., L.S.P., C.L.D., W.L.W.T., M.C.J.L., J.J., L.D.A.T., S.L.N., P.Y.Q.L. G.J.X.O., T.Y.N., Z.T., A.M.R., R.S.Y.F.), National University Health Systems, Singapore.
  • Haigh JJ; Cardiovascular Research Institute, Yong Loo Lin School of Medicine, National University of Singapore (Y.Z., M.A.-J., M.K.S., L.S.P., C.L.D., W.L.W.T., M.C.J.L., J.J., L.D.A.T., S.L.N., P.Y.Q.L. G.J.X.O., T.Y.N., Z.T., A.M.R., R.S.Y.F.).
  • Tiang Z; Cardiovascular Metabolic Disease Translational Research Programme (Y.Z., M.A.-J., M.K.S., L.S.P., C.L.D., W.L.W.T., M.C.J.L., J.J., L.D.A.T., S.L.N., P.Y.Q.L. G.J.X.O., T.Y.N., Z.T., A.M.R., R.S.Y.F.), National University Health Systems, Singapore.
  • Richards AM; Cardiovascular Research Institute, Yong Loo Lin School of Medicine, National University of Singapore (Y.Z., M.A.-J., M.K.S., L.S.P., C.L.D., W.L.W.T., M.C.J.L., J.J., L.D.A.T., S.L.N., P.Y.Q.L. G.J.X.O., T.Y.N., Z.T., A.M.R., R.S.Y.F.).
  • Foo RSY; Cardiovascular Metabolic Disease Translational Research Programme (Y.Z., M.A.-J., M.K.S., L.S.P., C.L.D., W.L.W.T., M.C.J.L., J.J., L.D.A.T., S.L.N., P.Y.Q.L. G.J.X.O., T.Y.N., Z.T., A.M.R., R.S.Y.F.), National University Health Systems, Singapore.
Circulation ; 149(23): 1833-1851, 2024 Jun 04.
Article em En | MEDLINE | ID: mdl-38586957
ABSTRACT

BACKGROUND:

Adult mammalian cardiomyocytes have limited proliferative capacity, but in specifically induced contexts they traverse through cell-cycle reentry, offering the potential for heart regeneration. Endogenous cardiomyocyte proliferation is preceded by cardiomyocyte dedifferentiation (CMDD), wherein adult cardiomyocytes revert to a less matured state that is distinct from the classical myocardial fetal stress gene response associated with heart failure. However, very little is known about CMDD as a defined cardiomyocyte cell state in transition.

METHODS:

Here, we leveraged 2 models of in vitro cultured adult mouse cardiomyocytes and in vivo adeno-associated virus serotype 9 cardiomyocyte-targeted delivery of reprogramming factors (Oct4, Sox2, Klf4, and Myc) in adult mice to study CMDD. We profiled their transcriptomes using RNA sequencing, in combination with multiple published data sets, with the aim of identifying a common denominator for tracking CMDD.

RESULTS:

RNA sequencing and integrated analysis identified Asparagine Synthetase (Asns) as a unique molecular marker gene well correlated with CMDD, required for increased asparagine and also for distinct fluxes in other amino acids. Although Asns overexpression in Oct4, Sox2, Klf4, and Myc cardiomyocytes augmented hallmarks of CMDD, Asns deficiency led to defective regeneration in the neonatal mouse myocardial infarction model, increased cell death of cultured adult cardiomyocytes, and reduced cell cycle in Oct4, Sox2, Klf4, and Myc cardiomyocytes, at least in part through disrupting the mammalian target of rapamycin complex 1 pathway.

CONCLUSIONS:

We discovered a novel gene Asns as both a molecular marker and an essential mediator, marking a distinct threshold that appears in common for at least 4 models of CMDD, and revealing an Asns/mammalian target of rapamycin complex 1 axis dependency for dedifferentiating cardiomyocytes. Further study will be needed to extrapolate and assess its relevance to other cell state transitions as well as in heart regeneration.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aspartato-Amônia Ligase / Miócitos Cardíacos / Desdiferenciação Celular / Fator 4 Semelhante a Kruppel Limite: Animals Idioma: En Revista: Circulation Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aspartato-Amônia Ligase / Miócitos Cardíacos / Desdiferenciação Celular / Fator 4 Semelhante a Kruppel Limite: Animals Idioma: En Revista: Circulation Ano de publicação: 2024 Tipo de documento: Article